InvestorsHub Logo
Followers 177
Posts 24339
Boards Moderated 12
Alias Born 04/03/2002

Re: jedijazz post# 2069

Tuesday, 12/11/2018 10:00:19 AM

Tuesday, December 11, 2018 10:00:19 AM

Post# of 4463
The IVST growth story of acquisition, partnership, new revenue generation and internal evolution is one of the most impressive on the OTC market right now. With all that is coming together here we should be seeing a lot more news coming up.

Note from yesterday's IVST press release:

Innovest's biotechnology division expects a variety of developments, from both StemVax and its new efforts. Innovest is enthusiastically closing out a year which was marked by a series of developments and revenue acquistions, which effectivelty set a platform that can scale significantly in 2019 and beyond.